Work

Developing endpoints for the cognitive burden in myotonic dystrophy type 1: A workshop report

Year: 2026
Type: article
Abstract: Myotonic Dystrophy Type 1 (DM1) is an autosomal dominant, repeat expansion, progressive multisystem disorder. While central nervous system (CNS) involvement has been well established, a consensus on a dedicated protocol to assess cognitive function and collect CNS biomarkers is still lacking in this disease. In the era of disease-modifying therapies that cross the blood-brain barrier (BBB), availability of mechanistically relevant neuropsychological probes and reliable biomarkers of DM1 pathology is no longer deferrable. Consequently, to better define and harmonize a CNS assessment pathway, the Myotonic Dystrophy Clinical Research Network (DMCRN) convened a workshop entitled ''Myotonic Dystrophy CNS Workshop'' in September 2024. Presenters described the protean manifestations of CNS involvement in DM1, shared data about neuropsychological assessments available with cross-fertilization from other neurological and neurodegenerative diseases and discussed existing data and future perspectives on CNS radiological biomarkers.
Language: English
Open Access status: hybrid
OpenAlex ID: W7236733926
FWCI:
Cites: 83
Cited by:
Related to: 10